ANI PHARMACEUTICALS INC — Director's Dealing 2020

Aug 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-08-05

Reporting Person: Pera Antonio R (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-05	Common Stock	A	7421	—	Acquired	7421	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-05	Stock Option (right to buy)	$31	A	16024	Acquired	2029-08-05	Common Stock (16024)	Direct

Footnotes

F1: Represents a restricted stock award that will vest as to 50% of the total shares on August 5, 2021 and the remaining 50% of the total shares on August 5, 2022.

F2: The option will vest and become exercisable as to 50% of the total shares on August 5, 2021 and the remaining 50% of the total shares on August 5, 2022.